Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00114309
What this trial is testing

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+3 more
TransMolecular 66
Early research (Phase 1)WithdrawnNCT06466798
What this trial is testing

Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies

Who this might be right for
Recurrent EpendymomaRecurrent MedulloblastomaCNS Malignancies
Jeffrey Treiber
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Early research (Phase 1)Study completedNCT02271711
What this trial is testing

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
M.D. Anderson Cancer Center 12
Not applicableStudy completedNCT00760409
What this trial is testing

Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI

Who this might be right for
Radiation InjuryBrain Tumor
University of Michigan 28
Testing effectiveness (Phase 2)WithdrawnNCT03925675
What this trial is testing

18F-Fluciclovine PET and Multiparametric MR Imaging

Who this might be right for
Brain Tumor, Recurrent, Adult
Loma Linda University
Testing effectiveness (Phase 2)Study completedNCT00213278
What this trial is testing

Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma

Who this might be right for
Glioma
The Hospital for Sick Children 50
Testing effectiveness (Phase 2)Study completedNCT00459381
What this trial is testing

Pazopanib in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00001328
What this trial is testing

Gene Therapy for the Treatment of Brain Tumors

Who this might be right for
Brain NeoplasmNeoplasm Metastasis
National Institute of Neurological Disorders and Stroke (NINDS) 15
Testing effectiveness (Phase 2)UnknownNCT01763385
What this trial is testing

Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases

Who this might be right for
Non-small-cell Lung CancerBrain Metastases
Wu Jieping Medical Foundation 210
Early research (Phase 1)Study completedNCT01480050
What this trial is testing

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Very early researchActive Not RecruitingNCT05651178
What this trial is testing

Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients

Who this might be right for
Central Nervous System Lymphoma
Hrain Biotechnology Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT03233204
What this trial is testing

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Childhood Non-Hodgkin LymphomaAnn Arbor Stage IV Childhood Non-Hodgkin Lymphoma+33 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT02652715
What this trial is testing

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more
Mayo Clinic 29
Early research (Phase 1)Study completedNCT00348985
What this trial is testing

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00221325
What this trial is testing

A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

Who this might be right for
Central Nervous System LymphomaIntraocular Lymphoma
University of California, San Francisco 14
Large-scale testing (Phase 3)Study completedNCT00002840
What this trial is testing

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 350
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03279692
What this trial is testing

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

Who this might be right for
High Grade Meningioma
Massachusetts General Hospital 26
Large-scale testing (Phase 3)Study completedNCT00003293
What this trial is testing

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Next Page